Atlas Trials

A Trial to Learn How Well REGN9933 Works for Preventing Blood Clots After Knee Replacement Surgery in Adult Participants

Clinical trial NCT05618808 · COMPLETED

Trial details

NCT number
NCT05618808
Sponsor
Regeneron Pharmaceuticals
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Venous Thromboembolism
Start date
2023-05-24
Primary completion
2024-05-27
Enrollment
373

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.